DEXCOM INC — Director's Dealing 2016

Mar 10, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2016-03-08

Reporting Person: GREGG TERRANCE H (Director, Executive Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-03-08	Common Stock	A	34000.0	$0.0010	Acquired	493018	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	11461	Indirect
Common Stock	301064	Indirect

Footnotes

F1: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and subject to vesting in one annual installment from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. common stock.

F2: Included in this number are 100,017 unvested restricted stock units, 34,000 of which were granted on March 8, 2016 and will vest on March 8, 2017, 60,938 unvested restricted stock units granted on March 8, 2014, 5,078 of which shall vest each month through March 8, 2017, and 5,079 unvested restricted stock units granted on March 11, 2013, which shall vest on March 11, 2016.

F3: Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee.